Girish Malhotra, PE

Improving Drug Affordability for the United States Population through Alternate Business Models
Tuesday, July 17, 2018
Recent layoffs and closures in the pharmaceutical industry have been on the horizon for some time. However, it seems the signs have been ignored. read more
Could Amazon (A), Berkshire Hathaway (B) and J.P. Morgan Chase (M) be the Anti-Ballistic Missile (ABM) Needed to Control...
Sunday, March 25, 2018
The recent announcement of Amazon, Berkshire Hathaway, and JP Morgan Chase to address rising healthcare costs for their employees has caused a bit of uproar on the healthcare landscape. Healthcare companies and many others ... read more
Comparison of Drugs Prices: US vs. India; Their Manufacturing Costs and Opportunities to Improve Affordability
Friday, February 16, 2018
In recent years in the United States there has been news about ever increasing drug prices and essentially ineffective calls/pressure and votes to lower them. read more
Batch, Continuous or “Fake/False” Continuous Processes
Sunday, October 15, 2017
Use of “Fake and/or False” in our vocabulary has become very pervasive since 2016. I thought it would be useful and helpful to re-visit the definitions of batch and continuous production processes and try to see if either of ... read more

Articles by Girish Malhotra, PE